Total Funding
3
Total FundingGrant raised
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Developer of a broadly-protective influenza therapeutic.
David Baker: Co-founder & Scientific Advisor
About the Company
Virvio is a pre-clinical biotherapeutic company developing a broadly-neutralizing peptide capable of both pre- and post- exposure containment of influenza. The drug candidate is being developed as a shelf-stable, single-dose, inhaled product suitable for stockpiling and global pandemic preparedness.
